Profile
Search

Pneumococcal Polysaccharide Vaccine

Uses

Pneumococcal Polysaccharide Vaccine is used for the prevention of pneumonia, meningitis, blood infections, and ear infections.

How it Works

How Pneumococcal Polysaccharide Vaccine Works Pneumococcal Polysaccharide Vaccine is a vaccine that helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies, which are proteins that protect against future infections.

Side Effects

Common side effects of the Pneumococcal Polysaccharide Vaccine include fever, injection site reactions (such as pain, swelling, and redness), fatigue, muscle pain, and headache.

Expert Advice

  • Pneumococcal Polysaccharide Vaccine is administered to prevent invasive diseases caused by pneumococcal bacteria, including:
    • Pneumonia
    • Meningitis
    • Ear infections
    • Blood infections
  • The vaccine is typically given as an intramuscular injection into the upper arm.
  • Only one dose is required for most individuals.
  • A booster dose may be administered 5 years after the initial dose.
  • Notify your doctor if you have an infection accompanied by a high temperature, as vaccination may need to be postponed until recovery.
  • The vaccine may cause fever.
  • Inform your doctor if the fever persists or exceeds 102 degrees Fahrenheit.

Frequently asked questions

Yes, the Pneumococcal Polysaccharide Vaccine is very safe, having undergone extensive testing and ongoing safety monitoring. Mild side effects like pain at the injection site or a low fever may occur but typically resolve within a few days. Consult a doctor if symptoms persist.
The Pneumococcal Polysaccharide Vaccine consists of long chains of polysaccharide molecules that form the bacterial capsule. These polysaccharides serve as antigens that stimulate the production of antibodies to combat infections.
No, the Pneumococcal Polysaccharide Vaccine contains no live virus; it is made from purified capsules of 23 types of pneumococcal bacteria and protects against most pneumococcal infections.
One dose of the Pneumococcal Polysaccharide Vaccine is usually sufficient, with a second dose considered only for those at increased risk of serious infections, typically 3-5 years after the first dose. A second dose within 3 years is not recommended due to higher side effect risks.
Yes, the Pneumococcal Polysaccharide Vaccine can be administered alongside the influenza vaccine, provided they are given with separate syringes and at different injection sites.
Individuals with minor illnesses, like a common cold, can receive the vaccine. However, those with high fever or significant illness should wait until recovery and consult a doctor before vaccination.
It is advisable to receive the Pneumococcal Polysaccharide Vaccine at least two weeks before planned spleen removal or chemotherapy. Vaccination should be avoided during chemotherapy or radiation, and ideally given at least 3 months after completing such treatments.

Flat ₹100 off on first app order   |    Use Code:  APP100   | 

Flat ₹100 off on first app order

USE CODE: APP100

PlatinumCare

Download Now

AppleIconPlayStoreIcon